Plus Therapeutics
NASDAQ: PSTVAustin, US · Delaware corporation
Founders & leadership
AS
Andrew SimsExecutive
RL
Robert LenkNamed on SEC filing
GP
Greg PetersenNamed on SEC filing
HC
Howard ClowesNamed on SEC filing
MH
Marc H. HedrickNamed on SEC filing
AV
An van Es-JohanssonNamed on SEC filing
RJ
Richard J. HawkinsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2020
▶$300KraisedMay 2020 · 1 investors · PharmaceuticalsRule 506(b)
▶$300KraisedMay 2020 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert LenkDirector
- Greg PetersenDirector
- Howard ClowesDirector
- Marc H. HedrickExecutive Officer, Director
- Andrew SimsExecutive Officer
- An van Es-JohanssonDirector
- Richard J. HawkinsDirector
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Plus Therapeutics raised?
- Plus Therapeutics has disclosed $300K raised across 1 round.
- Where is Plus Therapeutics headquartered?
- Plus Therapeutics is headquartered in Austin, US.